These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2074257

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
    Albin HC, Demotes-Mainard FM, Bouchet JL, Vincon GA, Martin-Dupont C.
    Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
    [Abstract] [Full Text] [Related]

  • 3. Cefotaxime and metabolite disposition in two pediatric continuous ambulatory peritoneal dialysis patients.
    Paap CM, Nahata MC, Mentser MA, Mahan JD, Puri SK, Hubbard JA.
    Ann Pharmacother; 1992 Mar; 26(3):341-3. PubMed ID: 1554953
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of cefodizime administered intravenously as a single-dose (1.0 and 2.0 g) to healthy adult volunteers.
    Bryskier A, Procyk T, Tremblay D, Lenfant B, Fourtillan JB.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():65-70. PubMed ID: 2074253
    [Abstract] [Full Text] [Related]

  • 5. Disposition of cefotaxime and desacetyl cefotaxime during continuous ambulatory peritoneal dialysis.
    Heim KL, Halstenson CE, Comty CM, Affrime MB, Matzke GR.
    Antimicrob Agents Chemother; 1986 Jul; 30(1):15-9. PubMed ID: 3752976
    [Abstract] [Full Text] [Related]

  • 6. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE, Hajdú P, Malerczyk V, de Looze S, Seeger K, Grötsch H.
    Clin Ther; 1987 Jul; 10(1):18-31. PubMed ID: 3450392
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of once daily intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
    Low CL, Gopalakrishna K, Lye WC.
    J Am Soc Nephrol; 2000 Jun; 11(6):1117-1121. PubMed ID: 10820176
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
    Manley HJ, Bailie GR, Asher RD, Eisele G, Frye RF.
    Perit Dial Int; 1999 Jun; 19(1):65-70. PubMed ID: 10201343
    [Abstract] [Full Text] [Related]

  • 9. The pharmacokinetics of cefodizime following intravenous and intramuscular administration of a single dose of 1.0 g.
    Bryskier A, Procyk T, Tremblay D, Lenfant B, Fourtillan JB.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():59-63. PubMed ID: 2074252
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis.
    Albin H, Ragnaud JM, Demotes-Mainard F, Vinçon G, Couzineau M, Wone C.
    Eur J Clin Pharmacol; 1986 Nov; 31(4):479-83. PubMed ID: 3816928
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis.
    Albin H, Ragnaud JM, Demotes-Mainard F, Vincon G, Wone C.
    Eur J Clin Pharmacol; 1986 Nov; 30(3):299-302. PubMed ID: 3732364
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of cefodizime in patients with various degrees of renal failure.
    Loffreda A, Lampa E, Lucarelli C, Amorena M, Contaldi C, Calderaro V, Rossi F.
    Chemotherapy; 1999 Nov; 45(1):1-7. PubMed ID: 9876203
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteers.
    Lenfant B, Namour F, Logeais C, Coussediere D, Rivault O, Bryskier A, Surjus A.
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2037-41. PubMed ID: 8540712
    [Abstract] [Full Text] [Related]

  • 14. The pharmacokinetics of cefodizime in children.
    Boccazzi A, Fusi G, Mezzopane AM, Maretti M, Careddu P.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():83-7. PubMed ID: 2074256
    [Abstract] [Full Text] [Related]

  • 15. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis (CAPD).
    Walker SE, Paton TW, Churchill DN, Ojo B, Manuel MA, Wright N.
    Perit Dial Int; 1989 Nov; 9(1):51-5. PubMed ID: 2488182
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacokinetics of cefotiam in patients undergoing continuous ambulatory peritoneal dialysis].
    Itagaki N, Hasegawa H, Tsujino M, Takahashi K, Yamamoto Y, Imada A, Horiuchi A.
    Jpn J Antibiot; 1988 Apr; 41(4):405-8. PubMed ID: 3165474
    [Abstract] [Full Text] [Related]

  • 17. Single-dose pefloxacin pharmacokinetics and metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nikolaidis P, Walker SE, Dombros N, Tourkantonis A, Paton TW, Oreopoulos DG.
    Perit Dial Int; 1991 Apr; 11(1):59-63. PubMed ID: 2049424
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of intraperitoneal, intravenous, and subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Ateshkadi A, Johnson CA, Oxton LL, Hammond TG, Bohenek WS, Zimmerman SW.
    Am J Kidney Dis; 1993 Jun; 21(6):635-42. PubMed ID: 8503418
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of intravenous ceftizoxime in patients on continuous ambulatory peritoneal dialysis.
    Johnson CA, Zimmerman SW, Bayer W, Craig WA.
    Clin Nephrol; 1985 Mar; 23(3):120-4. PubMed ID: 3857136
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of cefotaxime in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis.
    Hasegawa H, Imada A, Horiuchi A, Nishii Y, Fukushima M, Kurokawa E.
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():135-42. PubMed ID: 6094432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.